Roger K. Ng

Roger Ng practices at Manteca Medical Center in Manteca, California, part of Kaiser Permanente.

Roger Ng's NPI, 1407992076, was assigned on January 30, 2007. Roger Ng holds Washington license MD60750871.

Roger Ng's primary practice is Manteca Medical Center, at 1777 West Yosemite Ave, Manteca, CA 95337 in San Joaquin County. The practice phone is (209) 825-3700.

Roger Ng's primary practice is Manteca Medical Center in Manteca, California, part of Kaiser Permanente. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Roger Ng to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Roger Ng practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Roger Ng's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Roger Ng's licenses on file in 4 states: Washington, California, Massachusetts and Montana.

CMS data shows 1,889 Medicare services from Roger Ng across 15 procedure codes in 2024, for 1,028 Medicare patients. Medicare paid $182,604 for them.

CMS counts 1,028 Medicare patients who saw Roger Ng in 2024. The largest group is 75 to 84, with 383 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Roger Ng's median patient age at 58, with 56% women.

In 2024, Roger Ng wrote 1,248 Medicare Part D claims for 302 patients. 77% of them were for generic drugs. CMS names the drug for 1,084 of them, across 27 drugs with 11 or more claims each, at $205,106 in total drug cost. In 2023, CMS named 1,880 claims across 33 drugs.

Roger Ng accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Roger Ng from 16 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $217.